167 related articles for article (PubMed ID: 7678775)
1. Inhibition of angiogenesis by antiestrogens.
Gagliardi A; Collins DC
Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
[TBL] [Abstract][Full Text] [Related]
2. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen-stimulated growth of human endometrial carcinoma.
Jordan VC; Gottardis MM; Satyaswaroop PG
Ann N Y Acad Sci; 1991; 622():439-46. PubMed ID: 1905895
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors.
Gagliardi AR; Hennig B; Collins DC
Anticancer Res; 1996; 16(3A):1101-6. PubMed ID: 8702220
[TBL] [Abstract][Full Text] [Related]
6. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Musgrove EA; Wakeling AE; Sutherland RL
Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
[TBL] [Abstract][Full Text] [Related]
7. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ
Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
[TBL] [Abstract][Full Text] [Related]
8. Activity of tamoxifen and new antiestrogens on estrogen receptor positive and negative breast cancer cells.
Coradini D; Biffi A; Cappelletti V; Di Fronzo G
Anticancer Res; 1994; 14(3A):1059-64. PubMed ID: 8074450
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
10. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
Osborne CK; Boldt DH; Estrada P
Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
[TBL] [Abstract][Full Text] [Related]
11. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity.
Hyder SM; Chiappetta C; Stancel GM
Cancer Lett; 1997 Dec; 120(2):165-71. PubMed ID: 9461033
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial activities of nonsteroidal antiestrogens against leukemia.
Hayon T; Atlas L; Levy E; Dvilansky A; Shpilberg O; Nathan I
Cancer Detect Prev; 2003; 27(5):389-96. PubMed ID: 14585326
[TBL] [Abstract][Full Text] [Related]
13. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
Gottardis MM; Ricchio ME; Satyaswaroop PG; Jordan VC
Cancer Res; 1990 Jun; 50(11):3189-92. PubMed ID: 2334915
[TBL] [Abstract][Full Text] [Related]
14. Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.
Nicholson RI; Gee JM; Manning DL; Wakeling AE; Montano MM; Katzenellenbogen BS
Ann N Y Acad Sci; 1995 Jun; 761():148-63. PubMed ID: 7625718
[No Abstract] [Full Text] [Related]
15. Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine.
Maertens C; Droogmans G; Chakraborty P; Nilius B
Br J Pharmacol; 2001 Jan; 132(1):135-42. PubMed ID: 11156570
[TBL] [Abstract][Full Text] [Related]
16. Action of "pure" antiestrogens in inhibiting estrogen receptor action.
Parker MG
Breast Cancer Res Treat; 1993; 26(2):131-7. PubMed ID: 8219250
[TBL] [Abstract][Full Text] [Related]
17. Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element.
Xing H; Haase S; Shapiro DJ
Biochem Biophys Res Commun; 1994 Jul; 202(2):888-95. PubMed ID: 8048961
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antiproliferative properties of antiestrogenic drugs (nafoxidine and clomiphene) on glioma cells in vitro.
Yaz G; Kabadere S; Oztopçu P; Durmaz R; Uyar R
Am J Clin Oncol; 2004 Aug; 27(4):384-8. PubMed ID: 15289732
[TBL] [Abstract][Full Text] [Related]
19. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
20. The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
Liu JW; Jeannin E; Picard D
Biol Chem; 1999 Nov; 380(11):1341-5. PubMed ID: 10614829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
